Literature DB >> 26154090

Risk factors for Charcot foot.

Marta Barreto de Medeiros Nóbrega1, Roque Aras1, Eduardo Martins Netto1, Ricardo David Couto1, Alexandre Magno da Nóbrega Marinho2, João Luís da Silva3, Víctor Nóbrega Quintas Colares4, Priscilla Leite Campelo2, Marcos André Lima Nunes2.   

Abstract

OBJECTIVE: Diabetes mellitus is the main cause of Charcot neuroarthropathy and is clinically classified as follows: Charcot foot, acute Charcot foot (ACF) when there is inflammation, and inactive Charcot foot when inflammatory signs are absent. The aim of this study was to identify the risk factors for ACF in patients with type 2 diabetes mellitus.
MATERIALS AND METHODS: A matched case-control study was conducted to assess the factors associated with acute Charcot foot from February 2000 until September 2012. Four controls for each case were selected 47 cases of ACF and 188 controls without ACF were included. Cases and controls were matched by year of initialization of treatment. Conditional logistic regression was used to estimate matched odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULTS: In multivariate analysis, patients having less than 55 years of age (adjusted OR = 4.10, 95% CI = 1.69 - 9.94), literate education age (adjusted OR = 3.73, 95% CI = 1.40 - 9.92), living alone (adjusted OR = 5.84, 95% CI = 1.49 - 22.86), previous ulceration (adjusted OR = 4.84, 95% CI = 1.62 - 14.51) were at increased risk of ACF. However, peripheral arterial disease (adjusted OR = 0.16, 95% CI = 0.05 - 0.52) of 6.25 (1.92 - 20.0) was a protective factor. DISCUSSION: The results suggest that PCA in type 2 diabetes primarily affects patients under 55 who live alone, are literate, and have a prior history of ulcers, and that peripheral arterial disease is a protective factor.

Entities:  

Mesh:

Year:  2015        PMID: 26154090     DOI: 10.1590/2359-3997000000042

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  5 in total

1.  Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction.

Authors:  Jennifer Pasquier; Binitha Thomas; Jessica Hoarau-Véchot; Tala Odeh; Amal Robay; Omar Chidiac; Soha R Dargham; Rebal Turjoman; Anna Halama; Khalid Fakhro; Robert Menzies; Amin Jayyousi; Mahmoud Zirie; Jassim Al Suwaidi; Arash Rafii; Rayaz A Malik; Talal Talal; Charbel Abi Khalil
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

2.  Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study.

Authors:  Jean Paul Vwakya Wanzou; Patrick Sekimpi; Johnson Owonda Komagum; Frederick Nakwagala; Erisa Sabakaki Mwaka
Journal:  J Foot Ankle Res       Date:  2019-06-14       Impact factor: 2.303

Review 3.  Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy.

Authors:  Hong-Mou Zhao; Jia-Yu Diao; Xiao-Jun Liang; Feng Zhang; Ding-Jun Hao
Journal:  J Orthop Surg Res       Date:  2017-10-02       Impact factor: 2.359

4.  Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot.

Authors:  Jennifer Pasquier; Vimal Ramachandran; Moh'd Rasheed Abu-Qaoud; Binitha Thomas; Manasi J Benurwar; Omar Chidiac; Jessica Hoarau-Véchot; Amal Robay; Khalid Fakhro; Robert A Menzies; Amin Jayyousi; Mahmoud Zirie; Jassim Al Suwaidi; Rayaz A Malik; Talal K Talal; Seyed Hani Najafi-Shoushtari; Arash Rafii; Charbel Abi Khalil
Journal:  Epigenomics       Date:  2018-06-05       Impact factor: 4.778

5.  Bone Mineral Density in Diabetes Mellitus Foot Patients for Prediction of Diabetic Neuropathic Osteoarthropathic Fracture.

Authors:  Jae-Ho Cho; Tae-Hong Min; Dong-Il Chun; Sung-Hun Won; Su Yeon Park; Kwonwoo Kim; Young Yi
Journal:  J Bone Metab       Date:  2020-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.